Biotech & pharma
First human use of Catheter Robotics' "Amigo" at Leicester
11 May 2010
Dr André Ng of the University of Leicester has carried out the world's first heart rhythm treatment procedure using robotics
Gammaglobulin treatment may alow Alzheimer’s disease
By By Debra Kain | 11 May 2010
Novel treatment strategy saves kidneys with large cancerous tumors
By By Jackie Carr | 05 May 2010
The ability to surgically save kidneys following the destruction or removal of large tumors is challenging, yet highly desirable, in order to decrease the risk of kidney failure and protect cardiovascular health, say UCSD researchers. By Jackie Carr
Stem cells from surgery leftovers could repair damaged hearts
30 Apr 2010
Scientists have for the first time succeeded in extracting vital stem cells from sections of vein removed for heart bypass surgery.
Scientists find cells that mend broken heart
01 Apr 2010
Researchers create atlas of transcription factor combinations
By By Debra Kain | 15 Mar 2010
Protein shown to be natural Inhibitor of aging in fruit fly model
By By Debra Kain | 06 Mar 2010
Panacea Biotec develops Swine flu vaccine
03 Mar 2010
Stem cells rescue nerve cells by direct contact
22 Feb 2010
Genetic variant linked to biological ageing
19 Feb 2010
Scientists report breakthrough in HIV treatment
01 Feb 2010
US and British scientists claim to have grown a crystal that helped them unravel the structure of an enzyme called integrase, found in retroviruses like HIV.
Researchers create new 'smart' nanocapsule delivery system for use in protein therapy
21 Jan 2010
Nanocapsules are submicroscopic containers composed of an oily or aqueous core surrounded by a thin, permeable polymer membrane roughly several to tens of nanometers thick By Wileen Wong Kromhout
Latest articles
Featured articles
The decoupling paradox: Why Wall Street keeps funding AI despite $100 oil
By Axel Miller | 11 May 2026
AI infrastructure stocks continue rallying despite $100 oil as investors bet on productivity gains and semiconductor demand in 2026.
Hybrid bonding gains attention as AI chip packaging demand grows
By Cygnus | 23 Apr 2026
Hybrid bonding is driving AI chip packaging demand as backend technologies gain importance in the semiconductor supply chain.
The agentic transition: how enterprises are scaling AI from pilot to profit
By Cygnus | 22 Apr 2026
AI has entered its execution era. Discover how companies like Valeo and Microsoft are scaling agentic AI systems—from copilots to autonomous workflows driving real business impact.
Post-splashdown: What Artemis II taught us about the ‘deep space wall’
By Axel Miller | 15 Apr 2026
Artemis II splashdown marks a breakthrough in deep space exploration. Discover AVATAR radiation data, Orion’s distance record, and insights shaping NASA’s 2028 Moon mission.
Can aviation go green? The multi-billion dollar race for sustainable fuel
By Cygnus | 10 Apr 2026
Airlines are racing to adopt sustainable aviation fuel, but limited supply and high costs challenge the future of green aviation.
The battery race: who will control the future of electric vehicles?
By Axel Miller | 08 Apr 2026
The global battery race is reshaping the electric vehicle industry, with China, the US, and Europe competing for control over supply chains and technology.
AI vs governments: Who controls the future of intelligence?
By Cygnus | 07 Apr 2026
Governments and AI companies like OpenAI and Anthropic are shaping the future of intelligence amid rising policy conflicts and global competition.
Strait of Hormuz: how one chokepoint controls the global economy
By Axel Miller | 06 Apr 2026
The Strait of Hormuz is a critical global chokepoint. Learn how disruptions impact oil prices, shipping, and the global economy.
The $2 trillion AI infrastructure race: Who will control global compute?
By Cygnus | 06 Apr 2026
AI spending is set to exceed $2 trillion in 2026, driving a global race in data centers, chips, and energy infrastructure.
